Foot-and-mouth disease vaccines: progress and problems

References

• Brooksby JB. Portraits of viruses: foot-and-mouth disease virus. Intervirology. 1982;18:21–23.
   Web of Science ®Google Scholar
• Cartwright B, Chapman WG, Sharpe RT. Stimulation by heterotypic antigens of foot-and-mouth disease virus antibodies in vaccinated cattle. Res Vet Sci. 1982;32:338–342.
   PubMed Web of Science ®Google Scholar
• Mattion N, König G, Seki C, et al. Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease. Vaccine. 2004;22(31–32):4149–4162.
   PubMed Web of Science ®Google Scholar
• Paton DJ, Valarcher JF, Bergmann I, et al. Selection of foot and mouth disease vaccine strains–a review. Rev Sci Tech. 2005;24(3):981–993.
   PubMed Web of Science ®Google Scholar
• Barnard AL, Arriens A, Cox S, et al. Immune response characteristics following emergency vaccination of pigs against foot-and-mouth disease. Vaccine. 2005;23:1037–1047.
   PubMed Web of Science ®Google Scholar
• Horsington J, Zhang ZD, Bittner H, et al. Early protection in sheep against intratypic heterologous challenge with serotype O foot-and-mouth disease virus using high-potency, emergency vaccine. Vaccine. 2015;33(3):422–429.
   PubMed Web of Science ®Google Scholar
• Brown F. The history of research in foot-and-mouth disease. Virus Res. 2003;91(1):3–7.
   PubMed Web of Science ®Google Scholar
• Cottam EM, Wadsworth J, Shaw AE, et al. Transmission pathways of foot-and-mouth disease virus in the United Kingdom in 2007. PLoS Pathog. 2008;4:e1000050.
   PubMed Web of Science ®Google Scholar
• Alexandersen S, Zhang Z, Donaldson AI. Aspects of the persistence of foot-and mouth disease virus in animals-the carrier problem. Microbes Infect. 2002;4(10):1099–1110.
   PubMed Web of Science ®Google Scholar
• Dawe PS, Flanagan FO, Madekurozwa RL, et al. Natural transmission of foot-and-mouth disease virus from African buffalo (Syncerus caffer) to cattle in a wildlife area of Zimbabwe. Vet Rec. 1994 Mar 5;134(10):230–232.
   PubMed Web of Science ®Google Scholar
• Dawe PS, Sorensen K, Ferris NP, et al. Experimental transmission of foot-and-mouth disease virus from carrier African buffalo (Syncerus caffer) to cattle in Zimbabwe. Vet Rec. 1994;134(9):211–215.
   PubMed Web of Science ®Google Scholar
• Brown CC, Piccone ME, Mason PW, et al. Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. J Virol. 1996;70(8):5638–5641.
   PubMed Web of Science ®Google Scholar
• Mason PW, Piccone ME, McKenna TS, et al. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology. 1997;227(1):96–102.
   PubMed Web of Science ®Google Scholar
• Chinsangaram J, Mason PW, Grubman MJ. Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine. 1998;16(16):1516–1522.
   PubMed Web of Science ®Google Scholar
• Paton DJ, Füssel A-E, Vosloo W, et al. The use of serosurveys following emergency vaccination, to recover the status of “foot-and-mouth disease free where vaccination is not practised”. Vaccine. 2014;32:7050–7056.
   PubMed Web of Science ®Google Scholar
• Van Oirschot JT. Diva vaccines that reduce virus transmission. J Biotechnol. 1999;73(2–3):195–205.
   PubMed Web of Science ®Google Scholar
• Uddowla S, Hollister J, Pacheco JM, et al. A safe foot-and- mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals. J Virol. 2012;86:11675–11685.
   PubMed Web of Science ®Google Scholar
• Li P, Lu Z, Bai X, et al. Evaluation of a 3A-truncated foot-and-mouth disease virus in pigs for its potential as a marker vaccine. Vet Res. 2014;45(1):51.
   PubMed Web of Science ®Google Scholar
• Brown F, Crick J. Application of agar-gel diffusion analysis to a study of the antigenic structure of inactivated vaccines prepared from the virus of foot-and-mouth disease. J Immunol. 1995;82:444–447.
   Google Scholar
• Ceglowski WS. Antibody response to the noninfectious 7 mμ component of the virus of foot-and-mouth disease. Virology. 1965;25:328–330.
   PubMed Web of Science ®Google Scholar
• Hegde NR, Maddur MS, Rao PP, et al. Thermostable foot-and-mouth disease virus as a vaccine candidate for endemic countries: a perspective. Vaccine. 2009;27:2199–2201.
   PubMed Web of Science ®Google Scholar
• Mateo R, Luna E, Rincon V, et al. Engineering viable foot-and-mouth disease viruses with increased thermostability as a step in the development of improved vaccines. J Virol. 2008;82(24):12232–12240.
   PubMed Web of Science ®Google Scholar
• Rincón V, Rodríguez-Huete A, López-Argüello S, et al. Identification of the structural basis of thermal lability of a virus provides a rationale for improved vaccines. Structure. 2014;22(11):1560–1570.
   PubMed Web of Science ®Google Scholar
• Curry S, Abrams CC, Fry E, et al. Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids. J Virol. 1995;69:430–438.
   PubMed Web of Science ®Google Scholar
• Curry S, Fry E, Blakemore W, et al. Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus. J Virol. 1997;71:9743–9752.
   PubMed Web of Science ®Google Scholar
• Wang CY, Chang TY, Walfield AM, et al. Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine. 2002;20:2603–2610.
   PubMed Web of Science ®Google Scholar
• Cubillos C, De La Torre BG, Jakab A, et al. Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide. J Virol. 2008;82:7223–7230.
   PubMed Web of Science ®Google Scholar
• Shao -J-J, Wong CK, Lin T, et al. Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine. Clin Vaccine Immunol. 2011;18:143–149.
   PubMed Web of Science ®Google Scholar
• Zheng HX, He JJ, Guo JH, et al. Genetic characterization of a new pandemic Southeast Asia topotype strain of serotype O foot-and-mouth disease virus isolated in China during 2010. Virus Genes. 2012;44:80–88.
   PubMed Web of Science ®Google Scholar
• Cao YM, Lu ZJ, Li YL, et al. Poly (I: C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs. Antiviral Res. 2013;97:145–153.
   PubMed Web of Science ®Google Scholar
• Cao YM, Lu ZJ, Li D, et al. Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C). Vet Microbiol. 2014;168:294–301.
   PubMed Web of Science ®Google Scholar
• Taboga O, Tami C, Carrillo E, et al. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol. 1997;71:2606–2614.
   PubMed Web of Science ®Google Scholar
• Rodriguez LL, Barrera J, Kramer E, et al. A synthetic peptide containing the consensus sequence of the G–H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Vaccine. 2003;21(25–26):3751–3756.
   PubMed Web of Science ®Google Scholar
• Zhang ZZ, Pan L, Ding YZ, et al. Efficacy of synthetic peptide candidate vaccines against serotype-A foot-and-mouth disease virus in cattle. Appl Microbiol Biotechnol. 2015;99(3):1389–1398.
   PubMed Web of Science ®Google Scholar
• Ren JL, Yang L, Xu HF, et al. CpG oligodeoxy- nucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle. Vaccine. 2011;29:7960–7965.
   PubMed Web of Science ®Google Scholar
• Tacken PJ, Figdor CG. Targeted antigen delivery and activation of dendritic cells in vivo: steps towards cost effective vaccines. Semin Immunol. 2011;23:12–20.
   PubMed Web of Science ®Google Scholar
• Guo H-C, Sun S-Q, Jin Y, et al. Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle. Vet Res. 2013;44:48. doi:10.1186/1297-9716-44-48.
   PubMed Web of Science ®Google Scholar
• Cao YM, Lu ZJ, Sun JC, et al. Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs. Vet Microbiol. 2009;137(1–2):10–17.
   PubMed Web of Science ®Google Scholar
• Bhat SA, Saravanan P, Hosamani M, et al. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge. Res Vet Sci. 2013;95(3):1217–1223.
   PubMed Web of Science ®Google Scholar
• Mohana SB, Madhanmohan M, Sriraman R, et al. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency. Antivir Res. 2012;96(3):288–295.
   PubMed Web of Science ®Google Scholar
• Porta C, Kotecha A, Burman A, et al. Rational engineering of recombinant picornavirus capsids to produce safe, protective vaccine antigen. PLoS Pathog. 2013;9(3):e1003255.
   PubMed Web of Science ®Google Scholar
• Li ZY, Yi YZ, Yin XP, et al. Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine. PLoS ONE. 2008;3(5):e2273.
   PubMed Web of Science ®Google Scholar
• Li ZY, Yin XP, Yi YZ, et al. FMD subunit vaccine produced using a silkworm-baculovirus expression system: protective efficacy against two type Asia1 isolates in cattle. Vet Microbiol. 2011;149(1–2):99–103.
   PubMed Web of Science ®Google Scholar
• Li ZY, Yi YZ, Yin XP, et al. Development of a foot-and-mouth disease virus serotype A empty capsid subunit vaccine using silkworm (Bombyx mori) pupae. PLoS ONE. 2012;7(8):e43849.
   PubMed Web of Science ®Google Scholar
• Zheng M, Jin N, Zhang H, et al. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus. J Virol Methods. 2006;136(1–2):230–237.
   PubMed Web of Science ®Google Scholar
• Moraes MP, Mayr GA, Mason PW, et al. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine. 2002;20:1631–1639.
   PubMed Web of Science ®Google Scholar
• Pacheco JM, Brum MC, Moraes MP, et al. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology. 2005;337(2):205–209.
   PubMed Web of Science ®Google Scholar
• Lu Z, Bao H, Cao Y, et al. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease. Vaccine. 2008;26:G48-53.
   PubMed Web of Science ®Google Scholar
• Lee C-D, Sun H-C, Hu S-M, et al. An improved SUMO fusion protein system for effective production of native proteins. Protein Sci. 2008;17(7):1241–1248.
   PubMed Web of Science ®Google Scholar
• Lee C-D, Yan Y-P, Liang S-M, et al. Production of FMDV virus-like particles by a SUMO fusion protein approach in Escherichia coli. J Biomed Sci. 2009;16(1):69.
   PubMed Web of Science ®Google Scholar
• Grubman MJ, Diaz-San Segundo F, Dias CCA, et al. Use of replication-defective adenoviruses to develop vaccines and biotherapeutics against foot-and-mouth disease. Future Virol. 2012;7(8):767–778.
   Web of Science ®Google Scholar
• Diaz-San Segundo F, Dias CC, Moraes MP, et al. Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine. Virology. 2014;468-470:283–292.
   PubMed Web of Science ®Google Scholar
• Stahl-Hennig C, Eisenblatter M, Jasny E, et al. Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques. PLoS Pathog. 2009;5:e1000373.
   PubMed Web of Science ®Google Scholar